RxDoctor Payments Data

Dennis Williams, MD

Pain Medicine · Evans, GANPI 1235131525

Payments from drug & device makers

$1,522in general payments, 2019–2025

Across 77 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$476
  • Collegium Pharmaceutical, Inc.$258
  • Biodelivery Sciences International, Inc.$255
  • Daiichi Sankyo Inc.$196
  • IBSA Pharma Inc.$98
  • Boston Scientific$73
  • plus $166 from 8 others

What the payments were for

  • Food & beverage$1,522100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,522 in reported general payments places this provider in the 40th percentile of 203 pain medicine providers in Georgia.

See all pain medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$111,559
Medicare patients
115
Services billed
1,280

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Norgesic ForteOrphenadrine/Aspirin/Caffeine71$140,448
Diclofenac Sodium181$122,066
LofenaDiclofenac Potassium49$95,350
Dermacinrx LidocanLidocaine24$77,403
OxycontinOxycodone Hcl88$59,757
Cyclobenzaprine Hcl ErCyclobenzaprine Hcl217$39,990
Nucynta ErTapentadol Hcl48$38,930
ZtlidoLidocaine34$35,319
Lidocaine120$25,351
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen967$19,505
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen723$18,601
Fentanyl117$9,364
Xtampza ErOxycodone Myristate22$8,881
Morphine Sulfate ErMorphine Sulfate225$6,337
LinzessLinaclotide12$6,209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er$258$47,81170 claims
Scilex Pharmaceuticals Inc.Ztlido$476$35,31934 claims
AbbVieLinzess$22$6,20912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 203 pain medicine providers in Georgia.

Other pain medicine in Evans

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →